Skip to content

Charles River Laboratories International

NYSE: CRL · USD

Charles River Laboratories International financials

6 charts

Revenue

USD millions

$1,004.078M
Charles River Laboratories International Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2010 Q2$292.104M; Change unavailable vs FY 2010 Q1
FY 2010 Q3$276.081M; −5.5% vs FY 2010 Q2
FY 2010 Q4$267.886M; −3.0% vs FY 2010 Q3
FY 2011 Q1$285.843M; +6.7% vs FY 2010 Q4
FY 2011 Q2$288.263M; +0.8% vs FY 2011 Q1
FY 2011 Q3$277.579M; −3.7% vs FY 2011 Q2
FY 2011 Q4$290.962M; +4.8% vs FY 2011 Q3
FY 2012 Q1$285.981M; −1.7% vs FY 2011 Q4
FY 2012 Q2$284.723M; −0.4% vs FY 2012 Q1
FY 2012 Q3$278.686M; −2.1% vs FY 2012 Q2
FY 2012 Q4$280.14M; +0.5% vs FY 2012 Q3
FY 2013 Q1$291.238M; +4.0% vs FY 2012 Q4
FY 2013 Q2$292.933M; +0.6% vs FY 2013 Q1
FY 2013 Q3$292.129M; −0.3% vs FY 2013 Q2
FY 2013 Q4$289.228M; −1.0% vs FY 2013 Q3
FY 2014 Q1$299.368M; +3.5% vs FY 2013 Q4
FY 2014 Q2$341.179M; +14.0% vs FY 2014 Q1
FY 2014 Q3$327.567M; −4.0% vs FY 2014 Q2
FY 2014 Q4$329.548M; +0.6% vs FY 2014 Q3
FY 2015 Q1$320.414M; −2.8% vs FY 2014 Q4
FY 2015 Q2$339.573M; +6.0% vs FY 2015 Q1
FY 2015 Q3$349.465M; +2.9% vs FY 2015 Q2
FY 2015 Q4$353.85M; +1.3% vs FY 2015 Q3
FY 2016 Q1$354.868M; +0.3% vs FY 2015 Q4
FY 2016 Q2$434.055M; +22.3% vs FY 2016 Q1
FY 2016 Q3$425.72M; −1.9% vs FY 2016 Q2
FY 2016 Q4$466.789M; +9.6% vs FY 2016 Q3
FY 2017 Q1$445.763M; −4.5% vs FY 2016 Q4
FY 2017 Q2$469.129M; +5.2% vs FY 2017 Q1
FY 2017 Q3$464.232M; −1.0% vs FY 2017 Q2
FY 2017 Q4$478.477M; +3.1% vs FY 2017 Q3
FY 2018 Q1$493.97M; +3.2% vs FY 2017 Q4
FY 2018 Q2$585.301M; +18.5% vs FY 2018 Q1
FY 2018 Q3$585.295M; 0.0% vs FY 2018 Q2
FY 2018 Q4$601.53M; +2.8% vs FY 2018 Q3
FY 2019 Q1$604.569M; +0.5% vs FY 2018 Q4
FY 2019 Q2$657.568M; +8.8% vs FY 2019 Q1
FY 2019 Q3$667.951M; +1.6% vs FY 2019 Q2
FY 2019 Q4$691.138M; +3.5% vs FY 2019 Q3
FY 2020 Q1$707.059M; +2.3% vs FY 2019 Q4
FY 2020 Q2$682.584M; −3.5% vs FY 2020 Q1
FY 2020 Q3$743.3M; +8.9% vs FY 2020 Q2
FY 2020 Q4$790.99M; +6.4% vs FY 2020 Q3
FY 2021 Q1$824.566M; +4.2% vs FY 2020 Q4
FY 2021 Q2$914.607M; +10.9% vs FY 2021 Q1
FY 2021 Q3$895.937M; −2.0% vs FY 2021 Q2
FY 2021 Q4$905.05M; +1.0% vs FY 2021 Q3
FY 2022 Q1$913.929M; +1.0% vs FY 2021 Q4
FY 2022 Q2$973.131M; +6.5% vs FY 2022 Q1
FY 2022 Q3$989.157M; +1.6% vs FY 2022 Q2
FY 2022 Q4$1,099.843M; +11.2% vs FY 2022 Q3
FY 2023 Q1$1,029.373M; −6.4% vs FY 2022 Q4
FY 2023 Q2$1,059.937M; +3.0% vs FY 2023 Q1
FY 2023 Q3$1,026.623M; −3.1% vs FY 2023 Q2
FY 2023 Q4$1,013.476M; −1.3% vs FY 2023 Q3
FY 2024 Q1$1,011.56M; −0.2% vs FY 2023 Q4
FY 2024 Q2$1,026.117M; +1.4% vs FY 2024 Q1
FY 2024 Q3$1,009.763M; −1.6% vs FY 2024 Q2
FY 2024 Q4$1,002.549M; −0.7% vs FY 2024 Q3
FY 2025 Q1$984.168M; −1.8% vs FY 2024 Q4
FY 2025 Q2$1,032.135M; +4.9% vs FY 2025 Q1
FY 2025 Q3$1,004.852M; −2.6% vs FY 2025 Q2
FY 2025 Q4$994.227M; −1.1% vs FY 2025 Q3
FY 2026 Q1$995.83M; +0.2% vs FY 2025 Q4
FY 2026 Q2$1,004.078M; +0.8% vs FY 2026 Q1
Jun 26, 2010 through Sep 25, 2026

Free cash flow

USD millions

$148.62M
Charles River Laboratories International Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2010 Q2$47.428M; Change unavailable vs FY 2010 Q1
FY 2010 Q3$8.498M; −82.1% vs FY 2010 Q2
FY 2010 Q4$50.807M; +497.9% vs FY 2010 Q3
FY 2011 Q1$14.604M; −71.3% vs FY 2010 Q4
FY 2011 Q2$58.643M; +301.6% vs FY 2011 Q1
FY 2011 Q3$40.026M; −31.7% vs FY 2011 Q2
FY 2011 Q4$44.426M; +11.0% vs FY 2011 Q3
FY 2012 Q1$11.165M; −74.9% vs FY 2011 Q4
FY 2012 Q2$47.926M; +329.3% vs FY 2012 Q1
FY 2012 Q3$50.793M; +6.0% vs FY 2012 Q2
FY 2012 Q4$50.588M; −0.4% vs FY 2012 Q3
FY 2013 Q1$23.548M; −53.5% vs FY 2012 Q4
FY 2013 Q2$39.172M; +66.3% vs FY 2013 Q1
FY 2013 Q3$58.511M; +49.4% vs FY 2013 Q2
FY 2013 Q4$48.66M; −16.8% vs FY 2013 Q3
FY 2014 Q1$17.273M; −64.5% vs FY 2013 Q4
FY 2014 Q2$47.66M; +175.9% vs FY 2014 Q1
FY 2014 Q3$57.443M; +20.5% vs FY 2014 Q2
FY 2014 Q4$72.831M; +26.8% vs FY 2014 Q3
FY 2015 Q1$0.604M; −99.2% vs FY 2014 Q4
FY 2015 Q2$72.446M; +11894.4% vs FY 2015 Q1
FY 2015 Q3$77.837M; +7.4% vs FY 2015 Q2
FY 2015 Q4$74.095M; −4.8% vs FY 2015 Q3
FY 2016 Q1$30.289M; −59.1% vs FY 2015 Q4
FY 2016 Q2$66.187M; +118.5% vs FY 2016 Q1
FY 2016 Q3$60.038M; −9.3% vs FY 2016 Q2
FY 2016 Q4$88.573M; +47.5% vs FY 2016 Q3
FY 2017 Q1$18.109M; −79.6% vs FY 2016 Q4
FY 2017 Q2$84.327M; +365.7% vs FY 2017 Q1
FY 2017 Q3$37.474M; −55.6% vs FY 2017 Q2
FY 2017 Q4$95.733M; +155.5% vs FY 2017 Q3
FY 2018 Q1$32.325M; −66.2% vs FY 2017 Q4
FY 2018 Q2$102.659M; +217.6% vs FY 2018 Q1
FY 2018 Q3$94.805M; −7.7% vs FY 2018 Q2
FY 2018 Q4$71.297M; −24.8% vs FY 2018 Q3
FY 2019 Q1$-1.872M; −102.6% vs FY 2018 Q4
FY 2019 Q2$104.772M; +5696.8% vs FY 2019 Q1
FY 2019 Q3$120.684M; +15.2% vs FY 2019 Q2
FY 2019 Q4$116.838M; −3.2% vs FY 2019 Q3
FY 2020 Q1$42.869M; −63.3% vs FY 2019 Q4
FY 2020 Q2$135.506M; +216.1% vs FY 2020 Q1
FY 2020 Q3$151.115M; +11.5% vs FY 2020 Q2
FY 2020 Q4$50.525M; −66.6% vs FY 2020 Q3
FY 2021 Q1$142.199M; +181.4% vs FY 2020 Q4
FY 2021 Q2$140.159M; −1.4% vs FY 2021 Q1
FY 2021 Q3$119.186M; −15.0% vs FY 2021 Q2
FY 2021 Q4$130.483M; +9.5% vs FY 2021 Q3
FY 2022 Q1$22.166M; −83.0% vs FY 2021 Q4
FY 2022 Q2$66.622M; +200.6% vs FY 2022 Q1
FY 2022 Q3$60.386M; −9.4% vs FY 2022 Q2
FY 2022 Q4$145.733M; +141.3% vs FY 2022 Q3
FY 2023 Q1$2.508M; −98.3% vs FY 2022 Q4
FY 2023 Q2$80.739M; +3119.3% vs FY 2023 Q1
FY 2023 Q3$139.503M; +72.8% vs FY 2023 Q2
FY 2023 Q4$142.62M; +2.2% vs FY 2023 Q3
FY 2024 Q1$50.744M; −64.4% vs FY 2023 Q4
FY 2024 Q2$154.049M; +203.6% vs FY 2024 Q1
FY 2024 Q3$213.071M; +38.3% vs FY 2024 Q2
FY 2024 Q4$83.746M; −60.7% vs FY 2024 Q3
FY 2025 Q1$112.373M; +34.2% vs FY 2024 Q4
FY 2025 Q2$169.305M; +50.7% vs FY 2025 Q1
FY 2025 Q3$178.246M; +5.3% vs FY 2025 Q2
FY 2025 Q4$58.57M; −67.1% vs FY 2025 Q3
FY 2026 Q1$-14.831M; −125.3% vs FY 2025 Q4
FY 2026 Q2$148.62M; +1102.1% vs FY 2026 Q1

Net margin

%

-0.15%
Charles River Laboratories International Net margin. Reported fiscal history.
Fiscal period%
FY 2010 Q24.95%
FY 2010 Q3-9.03%
FY 2010 Q4-128.25%
FY 2011 Q110.96%
FY 2011 Q211.21%
FY 2011 Q36.81%
FY 2011 Q49.36%
FY 2012 Q19.28%
FY 2012 Q210.74%
FY 2012 Q37.97%
FY 2012 Q46.61%
FY 2013 Q18.85%
FY 2013 Q29.46%
FY 2013 Q310.69%
FY 2013 Q46.72%
FY 2014 Q110.81%
FY 2014 Q210.5%
FY 2014 Q39.88%
FY 2014 Q4—
FY 2015 Q19.87%
FY 2015 Q214.5%
FY 2015 Q310.84%
FY 2015 Q4—
FY 2016 Q110.47%
FY 2016 Q28.11%
FY 2016 Q38.86%
FY 2016 Q49.57%
FY 2017 Q110.49%
FY 2017 Q211.5%
FY 2017 Q311.3%
FY 2017 Q4-6.24%
FY 2018 Q110.65%
FY 2018 Q29.18%
FY 2018 Q310.31%
FY 2018 Q49.92%
FY 2019 Q19.12%
FY 2019 Q26.65%
FY 2019 Q310.9%
FY 2019 Q411.63%
FY 2020 Q17.18%
FY 2020 Q29.88%
FY 2020 Q313.84%
FY 2020 Q418.1%
FY 2021 Q17.46%
FY 2021 Q29.67%
FY 2021 Q311.54%
FY 2021 Q415.2%
FY 2022 Q110.18%
FY 2022 Q211.23%
FY 2022 Q39.75%
FY 2022 Q417.04%
FY 2023 Q110.02%
FY 2023 Q29.15%
FY 2023 Q38.51%
FY 2023 Q418.46%
FY 2024 Q17.21%
FY 2024 Q29.17%
FY 2024 Q36.9%
FY 2024 Q4-21.39%
FY 2025 Q12.59%
FY 2025 Q25.07%
FY 2025 Q35.42%
FY 2025 Q4-27.82%
FY 2026 Q1-1.49%
FY 2026 Q2-0.15%

P/E

× · TTM · Daily

—
Charles River Laboratories International P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2012-02-2915.63×2011-12-31
2012-03-3016.06×2011-12-31
2012-04-3015.81×2011-12-31
2012-05-3115.55×2012-03-31
2012-06-2915.26×2012-03-31
2012-07-3115.86×2012-03-31
2012-08-3117.1×2012-06-30
2012-09-2818.65×2012-06-30
2012-10-3117.57×2012-06-30
2012-11-3017.42×2012-09-29
2012-12-3117.01×2012-09-29
2013-01-3118.75×2012-09-29
2013-02-2820.18×2012-12-29
2013-03-2821.93×2012-12-29
2013-04-3021.54×2012-12-29
2013-05-3121.75×2013-03-30
2013-06-2820.61×2013-03-30
2013-07-3122.87×2013-03-30
2013-08-3023.13×2013-03-30
2013-09-3023.24×2013-03-30
2013-10-3124.72×2013-03-30
2013-11-2926.2×2013-03-30
2013-12-3126.64×2013-03-30
2014-01-3128.39×2013-03-30
2014-02-2829.84×2013-03-30
2014-03-3130.31×2013-03-30
2014-04-3026.98×2013-03-30
2014-05-3026.91×2013-03-30
2014-06-3026.88×2013-03-30
2014-07-3127.23×2013-03-30
2014-08-2930.95×2013-06-29
2014-09-3031.29×2013-06-29
2014-10-3129.95×2013-09-28
2014-11-2830.71×2013-09-28
2014-12-3130.18×2013-09-28
2015-01-3032.89×2013-09-28
2015-02-2736.36×2013-09-28
2015-03-3137.6×2013-09-28
2015-04-3032.8×2013-09-28
2015-05-2934.31×2013-09-28
2015-06-3033.36×2013-09-28
2015-07-3136.81×2013-09-28
2015-08-3132.67×2013-09-28
2015-09-3030.12×2013-09-28
2015-10-3030.94×2013-09-28
2015-11-3036.31×2013-09-28
2015-12-3138.12×2013-09-28
2016-01-2935.2×2013-09-28
2016-02-2923.99×2015-09-26
2016-03-3124.81×2015-09-26
2016-04-2925.9×2015-09-26
2016-05-3126.41×2016-03-26
2016-06-3025.34×2016-03-26
2016-07-2927.03×2016-03-26
2016-08-3128.16×2016-06-25
2016-09-3028.2×2016-06-25
2016-10-3125.68×2016-06-25
2016-11-3024.06×2016-09-24
2016-12-3025.78×2016-09-24
2017-01-3127.34×2016-09-24
2017-02-2827.14×2016-12-31
2017-03-3128.07×2016-12-31
2017-04-2827.99×2016-12-31
2017-05-3128.72×2016-12-31
2017-06-3031.56×2016-12-31
2017-07-3130.64×2016-12-31
2017-08-3133.95×2016-12-31
2017-09-2933.71×2016-12-31
2017-10-3136.29×2016-12-31
2017-11-3025.48×2017-09-30
2017-12-2926.76×2017-09-30
2018-01-3125.78×2017-09-30
2018-02-2842.29×2017-12-30
2018-03-2942.34×2017-12-30
2018-04-3041.33×2017-12-30
2018-05-3140.63×2018-03-31
2018-06-2942.42×2018-03-31
2018-07-3146.97×2018-03-31
2018-08-3146.97×2018-06-30
2018-09-2851.16×2018-06-30
2018-10-3146.33×2018-06-30
2018-11-3048.6×2018-09-29
2018-12-3140.79×2018-09-29
2019-01-3144.4×2018-09-29
2019-02-2830.6×2018-12-29
2019-03-2931.26×2018-12-29
2019-04-3030.23×2018-12-29
2019-05-3127×2018-12-29
2019-06-2830.54×2018-12-29
2019-07-3128.95×2018-12-29
2019-08-3028.24×2018-12-29
2019-09-3028.49×2018-12-29
2019-10-3127.97×2018-12-29
2019-11-2931.26×2018-12-29
2019-12-3132.88×2018-12-29
2020-01-3133.27×2018-12-29
2020-02-2830.8×2019-12-28
2020-03-3124.99×2019-12-28
2020-04-3028.64×2019-12-28
2020-05-2935.57×2019-12-28
2020-06-3034.52×2019-12-28
2020-07-3139.39×2019-12-28
2020-08-3143.34×2019-12-28
2020-09-3044.83×2019-12-28
2020-10-3038.3×2020-09-26
2020-11-3039.44×2020-09-26
2020-12-3142.02×2020-09-26
2021-01-2943.57×2020-09-26
2021-02-2640.32×2020-12-26
2021-03-3140.84×2020-12-26
2021-04-3046.84×2020-12-26
2021-05-2847.62×2020-12-26
2021-06-3052.12×2020-12-26
2021-07-3057.34×2020-12-26
2021-08-3162.54×2020-12-26
2021-09-3058.15×2020-12-26
2021-10-2963.22×2020-12-26
2021-11-3051.55×2020-12-26
2021-12-3153.09×2020-12-26
2022-01-3146.46×2020-12-26
2022-02-2838.44×2021-12-25
2022-03-3137.49×2021-12-25
2022-04-2931.89×2021-12-25
2022-05-3128.44×2022-03-26
2022-06-3025.99×2022-03-26
2022-07-2930.44×2022-03-26
2022-08-3123.74×2022-06-25
2022-09-3022.76×2022-06-25
2022-10-3124.55×2022-06-25
2022-11-3026.86×2022-09-24
2022-12-3025.61×2022-09-24
2023-01-3128.59×2022-09-24
2023-02-2823.16×2022-12-31
2023-03-3121.31×2022-12-31
2023-04-2820.08×2022-12-31
2023-05-3120.42×2022-12-31
2023-06-3022.2×2022-12-31
2023-07-3122.13×2022-12-31
2023-08-3121.84×2022-12-31
2023-09-2920.7×2022-12-31
2023-10-3117.78×2022-12-31
2023-11-3020.81×2022-12-31
2023-12-2924.96×2022-12-31
2024-01-3122.84×2022-12-31
2024-02-2927.49×2023-12-30
2024-03-2829.3×2023-12-30
2024-04-3024.76×2023-12-30
2024-05-3122.54×2023-12-30
2024-06-2822.34×2023-12-30
2024-07-3126.4×2023-12-30
2024-08-3021.38×2023-12-30
2024-09-3021.3×2023-12-30
2024-10-3119.31×2023-12-30
2024-11-2924.86×2024-09-28
2024-12-3123.05×2024-09-28
2025-01-3120.57×2024-09-28
2025-02-28824.75×2024-12-28
2025-03-31750.96×2024-12-28
2025-04-30591.81×2024-12-28
2025-05-30—2025-03-29
2025-06-30—2025-03-29
2025-07-31—2025-03-29
2025-08-29—2025-06-28
2025-09-30—2025-06-28
2025-10-31—2025-06-28
2025-11-28—2025-09-27
2025-12-31—2025-09-27
2026-01-30—2025-09-27
2026-02-27—2025-12-27
2026-03-31—2025-12-27
2026-04-30—2025-12-27
2026-05-29—2026-03-28
2026-06-30—2026-03-28
2026-07-31—2026-03-28
2026-08-31—2026-06-27
2026-09-25—2026-06-27
Mean 41.84×Median 28.39×

ROIC

% · Annual / TTM

—
Charles River Laboratories International ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2010 Q2—
FY 2010 Q3—
FY 2010 Q4—
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q412.72%
FY 2012 Q111.27%
FY 2012 Q211.1%
FY 2012 Q311.29%
FY 2012 Q411.17%
FY 2013 Q110.82%
FY 2013 Q210.61%
FY 2013 Q310.57%
FY 2013 Q49.89%
FY 2014 Q19.75%
FY 2014 Q29.26%
FY 2014 Q39.76%
FY 2014 Q410.54%
FY 2015 Q111.37%
FY 2015 Q211.09%
FY 2015 Q311.02%
FY 2015 Q411.57%
FY 2016 Q111.35%
FY 2016 Q28.91%
FY 2016 Q38.67%
FY 2016 Q49.67%
FY 2017 Q19.89%
FY 2017 Q29.38%
FY 2017 Q39.82%
FY 2017 Q46.1%
FY 2018 Q16.64%
FY 2018 Q25.53%
FY 2018 Q35.98%
FY 2018 Q411.09%
FY 2019 Q110.9%
FY 2019 Q28.84%
FY 2019 Q39.68%
FY 2019 Q49.65%
FY 2020 Q1—
FY 2020 Q2—
FY 2020 Q3—
FY 2020 Q49.88%
FY 2021 Q1—
FY 2021 Q2—
FY 2021 Q3—
FY 2021 Q411.08%
FY 2022 Q1—
FY 2022 Q2—
FY 2022 Q3—
FY 2022 Q49.88%
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q48.92%
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q41.07%
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q4—
FY 2026 Q1—
FY 2026 Q2—

Capital allocation

% of tracked cash uses

$208.949M
Charles River Laboratories International capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2010 Q299.18% · $8.432MUnavailable0.82% · $0.07MUnavailableUnavailable100% · $8.502M
FY 2010 Q32.52% · $9.128MUnavailable97.48% · $353.456MUnavailableUnavailable100% · $362.584M
FY 2010 Q499.34% · $16.007MUnavailable0.66% · $0.106MUnavailableUnavailable100% · $16.113M
FY 2011 Q13.75% · $6.789MUnavailable96.25% · $174.465MUnavailableUnavailable100% · $181.254M
FY 2011 Q228.58% · $6.661MUnavailable71.42% · $16.644MUnavailableUnavailable100% · $23.305M
FY 2011 Q311.31% · $8.222MUnavailable88.69% · $64.501MUnavailableUnavailable100% · $72.723M
FY 2011 Q449.36% · $27.471M0% · $0M50.64% · $28.185MUnavailableUnavailable100% · $55.656M
FY 2012 Q148.07% · $14.112M0% · $0M51.93% · $15.246MUnavailableUnavailable100% · $29.358M
FY 2012 Q237.75% · $9.441M0% · $0M62.25% · $15.567MUnavailableUnavailable100% · $25.008M
FY 2012 Q324.29% · $10.242M40.08% · $16.902M35.64% · $15.029MUnavailableUnavailable100% · $42.173M
FY 2012 Q442.82% · $13.739MUnavailable57.18% · $18.347MUnavailableUnavailable100% · $32.086M
FY 2013 Q115.38% · $6.429M57.75% · $24.141M26.86% · $11.229MUnavailableUnavailable100% · $41.799M
FY 2013 Q238.35% · $9.794M0.3% · $0.077M61.35% · $15.67MUnavailableUnavailable100% · $25.541M
FY 2013 Q312.31% · $9.096M0% · $0M87.69% · $64.804MUnavailableUnavailable100% · $73.9M
FY 2013 Q414.87% · $13.835M5.37% · $5M79.76% · $74.229MUnavailableUnavailable100% · $93.064M
FY 2014 Q134.97% · $11.19M0% · $0M65.03% · $20.812MUnavailableUnavailable100% · $32.002M
FY 2014 Q23.41% · $9.315M67.02% · $183.151M29.57% · $80.797MUnavailableUnavailable100% · $273.263M
FY 2014 Q331.57% · $9.402M0% · $0M68.43% · $20.376MUnavailableUnavailable100% · $29.778M
FY 2014 Q434.56% · $27.018M65.39% · $51.116M0.04% · $0.033MUnavailableUnavailable100% · $78.167M
FY 2015 Q115.17% · $10.648M1.27% · $0.893M83.55% · $58.632MUnavailableUnavailable100% · $70.173M
FY 2015 Q221.55% · $13.908M15.16% · $9.787M63.29% · $40.854MUnavailableUnavailable100% · $64.549M
FY 2015 Q34.55% · $10.452M87.64% · $201.294M7.81% · $17.945MUnavailableUnavailable100% · $229.691M
FY 2015 Q444.15% · $28.244M55.77% · $35.677M0.07% · $0.047MUnavailableUnavailable100% · $63.968M
FY 2016 Q139.83% · $8.25M1.54% · $0.318M58.64% · $12.147MUnavailableUnavailable100% · $20.715M
FY 2016 Q22% · $11.791M97.99% · $578.454M0.01% · $0.051MUnavailableUnavailable100% · $590.296M
FY 2016 Q333.65% · $9.568M66.25% · $18.835M0.1% · $0.028MUnavailableUnavailable100% · $28.431M
FY 2016 Q433.53% · $25.679M66.42% · $50.875M0.05% · $0.041MUnavailableUnavailable100% · $76.595M
FY 2017 Q124.84% · $15.92M0% · $0M75.16% · $48.18MUnavailableUnavailable100% · $64.1M
FY 2017 Q241.4% · $15.997M0% · $0M58.6% · $22.64MUnavailableUnavailable100% · $38.637M
FY 2017 Q327.32% · $22.011M27.89% · $22.474M44.79% · $36.082MUnavailableUnavailable100% · $80.567M
FY 2017 Q491.8% · $28.503M8.17% · $2.538M0.02% · $0.007MUnavailableUnavailable100% · $31.048M
FY 2018 Q145.09% · $27.726M32.88% · $20.216M22.03% · $13.549MUnavailableUnavailable100% · $61.491M
FY 2018 Q22.58% · $21.213M97.41% · $801.134M0.01% · $0.119MUnavailableUnavailable100% · $822.466M
FY 2018 Q394.19% · $22.439M5.29% · $1.261M0.52% · $0.123MUnavailableUnavailable100% · $23.823M
FY 2018 Q496.74% · $68.676M3.18% · $2.257M0.08% · $0.055MUnavailableUnavailable100% · $70.988M
FY 2019 Q147.16% · $16.731M2.79% · $0.989M50.06% · $17.76MUnavailableUnavailable100% · $35.48M
FY 2019 Q24.8% · $24.781M95.18% · $491.392M0.02% · $0.123MUnavailableUnavailable100% · $516.296M
FY 2019 Q360.02% · $35.163M39.71% · $23.266M0.27% · $0.157MUnavailableUnavailable100% · $58.586M
FY 2019 Q499.84% · $63.839M0.08% · $0.054M0.07% · $0.047MUnavailableUnavailable100% · $63.94M
FY 2020 Q15.96% · $25.721M88.56% · $382.25M5.48% · $23.675MUnavailableUnavailable100% · $431.646M
FY 2020 Q299.56% · $26.8M0% · $0M0.44% · $0.118MUnavailableUnavailable100% · $26.918M
FY 2020 Q341.44% · $26.185M58.39% · $36.896M0.18% · $0.112MUnavailableUnavailable100% · $63.193M
FY 2020 Q499.92% · $87.854MUnavailable0.08% · $0.074MUnavailableUnavailable100% · $87.928M
FY 2021 Q117.71% · $28.03M59.52% · $94.197M22.77% · $36.028MUnavailableUnavailable100% · $158.255M
FY 2021 Q24.85% · $46.431M94.7% · $906.308M0.45% · $4.269MUnavailableUnavailable100% · $957.008M
FY 2021 Q315.99% · $55.536M83.97% · $291.588M0.04% · $0.143MUnavailableUnavailable100% · $347.267M
FY 2021 Q498.73% · $98.775M1% · $1.002M0.27% · $0.267MUnavailableUnavailable100% · $100.044M
FY 2022 Q170.3% · $80.464M0% · $0M29.7% · $33.994MUnavailableUnavailable100% · $114.458M
FY 2022 Q222.35% · $82.852M76.44% · $283.392M1.21% · $4.474MUnavailableUnavailable100% · $370.718M
FY 2022 Q399.97% · $72.393M0% · $0M0.03% · $0.024MUnavailableUnavailable100% · $72.417M
FY 2022 Q499.82% · $89.024M0% · $0M0.18% · $0.159MUnavailableUnavailable100% · $89.183M
FY 2023 Q160.71% · $106.875M28.49% · $50.166M10.8% · $19.012MUnavailableUnavailable100% · $176.053M
FY 2023 Q293.14% · $67.383M0% · $0M6.86% · $4.966MUnavailableUnavailable100% · $72.349M
FY 2023 Q399.94% · $65.947M0% · $0M0.06% · $0.038MUnavailableUnavailable100% · $65.985M
FY 2023 Q435.11% · $78.323M64.83% · $144.619M0.06% · $0.139MUnavailableUnavailable100% · $223.081M
FY 2024 Q189.43% · $79.144M0% · $0M10.57% · $9.351MUnavailableUnavailable100% · $88.495M
FY 2024 Q273.29% · $39.486M10.17% · $5.479M16.54% · $8.914MUnavailableUnavailable100% · $53.879M
FY 2024 Q327.76% · $38.721M0% · $0M72.24% · $100.786MUnavailableUnavailable100% · $139.507M
FY 2024 Q499.84% · $75.616M0% · $0M0.16% · $0.124MUnavailableUnavailable100% · $75.74M
FY 2025 Q114.38% · $59.324M0% · $0M85.62% · $353.132MUnavailableUnavailable100% · $412.456M
FY 2025 Q282.76% · $35.298M0% · $0M17.24% · $7.352MUnavailableUnavailable100% · $42.65M
FY 2025 Q399.74% · $35.58M0% · $0M0.26% · $0.093MUnavailableUnavailable100% · $35.673M
FY 2025 Q499.89% · $88.95M0% · $0M0.11% · $0.096MUnavailableUnavailable100% · $89.046M
FY 2026 Q18.35% · $55.908M60.52% · $405.006M31.12% · $208.285MUnavailableUnavailable100% · $669.199M
FY 2026 Q214.89% · $31.105M29.79% · $62.248M55.32% · $115.596MUnavailableUnavailable100% · $208.949M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Charles River Laboratories International.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources